188 related articles for article (PubMed ID: 26589287)
1. Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
Abshagen K; König M; Hoppe A; Müller I; Ebert M; Weng H; Holzhütter HG; Zanger UM; Bode J; Vollmar B; Thomas M; Dooley S
BMC Syst Biol; 2015 Nov; 9():83. PubMed ID: 26589287
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
Wang H; Vohra BP; Zhang Y; Heuckeroth RO
Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
[TBL] [Abstract][Full Text] [Related]
3. Characterization of time-related changes after experimental bile duct ligation.
Georgiev P; Jochum W; Heinrich S; Jang JH; Nocito A; Dahm F; Clavien PA
Br J Surg; 2008 May; 95(5):646-56. PubMed ID: 18196571
[TBL] [Abstract][Full Text] [Related]
4. Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.
Dondorf F; Fahrner R; Ardelt M; Patsenker E; Stickel F; Dahmen U; Settmacher U; Rauchfuß F
World J Gastroenterol; 2017 Jun; 23(23):4191-4199. PubMed ID: 28694659
[TBL] [Abstract][Full Text] [Related]
5. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
[TBL] [Abstract][Full Text] [Related]
7. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis.
Park YJ; Qatanani M; Chua SS; LaRey JL; Johnson SA; Watanabe M; Moore DD; Lee YK
Hepatology; 2008 May; 47(5):1578-86. PubMed ID: 18393320
[TBL] [Abstract][Full Text] [Related]
8. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
9. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
10. Bile duct ligation in developing rats: temporal progression of liver, kidney, and brain damage.
Sheen JM; Huang LT; Hsieh CS; Chen CC; Wang JY; Tain YL
J Pediatr Surg; 2010 Aug; 45(8):1650-8. PubMed ID: 20713215
[TBL] [Abstract][Full Text] [Related]
11. The Role of Phospho-c-Jun N-Terminal Kinase Expression on hepatocyte Necrosis and Autophagy in the Cholestatic Liver.
Kwak BJ; Choi HJ; Kim OH; Kim KH; You YK; Lee TY; Ahn J; Kim SJ
J Surg Res; 2019 Sep; 241():254-263. PubMed ID: 31035140
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats.
Abdel Kawy HS
Eur J Pharmacol; 2015 Apr; 752():8-17. PubMed ID: 25666386
[TBL] [Abstract][Full Text] [Related]
13. Induction of experimental obstructive cholestasis in mice.
Tag CG; Weiskirchen S; Hittatiya K; Tacke F; Tolba RH; Weiskirchen R
Lab Anim; 2015 Apr; 49(1 Suppl):70-80. PubMed ID: 25835740
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 aggravates hepatic ischemia/reperfusion injury during obstructive cholestasis in bile duct ligated mice.
Nagai H; Kato A; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Furukawa K; Nozawa S; Yoshitomi H; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
J Surg Res; 2010 Jul; 162(1):46-53. PubMed ID: 20552721
[TBL] [Abstract][Full Text] [Related]
15. The effects of Nigella sativa on bile duct ligation induced-liver injury in rats.
Coban S; Yildiz F; Terzi A; Al B; Aksoy N; Bitiren M; Celik H
Cell Biochem Funct; 2010 Jan; 28(1):83-8. PubMed ID: 20029957
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury.
Zhang J; Guo X; Hamada T; Yokoyama S; Nakamura Y; Zheng J; Kurose N; Ishigaki Y; Uramoto H; Tanimoto A; Yamada S
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149550
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation.
Shen K; Feng X; Su R; Xie H; Zhou L; Zheng S
PLoS One; 2015; 10(5):e0126278. PubMed ID: 25955525
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
[TBL] [Abstract][Full Text] [Related]
19. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor type I gene-deficient bile duct-ligated mice are partially protected against endotoxin.
Sewnath ME; Van Der Poll T; Ten Kate FJ; Van Noorden CJ; Gouma DJ
Hepatology; 2002 Jan; 35(1):149-58. PubMed ID: 11786971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
